Shelby Walker
Trading-Equity presso Becker Capital Management, Inc.
Patrimonio netto: - $ in data 30/04/2024
Posizioni attive di Shelby Walker
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Becker Capital Management, Inc.
 Becker Capital Management, Inc. Investment ManagersFinance Becker Capital Management, Inc. (BCM) is an independent, SEC-registered investment advisor headquartered in Portland, Oregon and additional office in Seattle, Washington. The firm was founded by Patrick Becker, Sr. in 1976. BCM provides a range of investment management services for high-net-worth individuals, families, institutional investors and nonprofit organizations. | Trading-Equity | 01/01/1997 | - |
Storia della carriera di Shelby Walker
Precedenti posizioni note di Shelby Walker
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CRISPR THERAPEUTICS AG | Corporate Officer/Principal | 01/03/2018 | 01/04/2023 |
| Gingko Bioworks | Consigliere Generale | 01/05/2016 | 01/03/2018 |
| DYAX CORP. | Consigliere Generale | 01/09/2010 | 01/06/2016 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Novo Nordisk Pharma AG
 Novo Nordisk Pharma AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma AG engages in the research, development, production, and distribution of products for the treatment of diabetes. It also specializes in the areas of obesity, blood coagulation, as well as growth hormones and hormone replacement therapy. The company was founded on February 17, 1930 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | - | - |
Formazione di Shelby Walker
| University of New Hampshire School of Law | Graduate Degree |
| The Johns Hopkins University | Graduate Degree |
| Worcester Polytechnic Institute | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
| Svizzera | 3 |
Posizioni
| Corporate Officer/Principal | 3 |
| General Counsel | 3 |
| Graduate Degree | 2 |
Settori
| Health Technology | 5 |
| Consumer Services | 4 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| Aziende private | 5 |
|---|---|
Becker Capital Management, Inc.
Becker Capital Management, Inc. Investment ManagersFinance Becker Capital Management, Inc. (BCM) is an independent, SEC-registered investment advisor headquartered in Portland, Oregon and additional office in Seattle, Washington. The firm was founded by Patrick Becker, Sr. in 1976. BCM provides a range of investment management services for high-net-worth individuals, families, institutional investors and nonprofit organizations. | Finance |
| Gingko Bioworks | |
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Novo Nordisk Pharma AG
Novo Nordisk Pharma AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma AG engages in the research, development, production, and distribution of products for the treatment of diabetes. It also specializes in the areas of obesity, blood coagulation, as well as growth hormones and hormone replacement therapy. The company was founded on February 17, 1930 and is headquartered in Zurich, Switzerland. | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Shelby Walker
- Esperienza
